G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 81 filers reported holding G1 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $66,371 | -7.1% | 26,655 | 0.0% | 0.00% | – |
Q1 2023 | $71,435 | -93.4% | 26,655 | -86.7% | 0.00% | -100.0% |
Q4 2022 | $1,086,000 | +1623.8% | 200,000 | +1480.3% | 0.01% | +400.0% |
Q2 2022 | $63,000 | -98.9% | 12,656 | -88.5% | 0.00% | -98.2% |
Q3 2018 | $5,770,000 | +357.9% | 110,348 | +224.4% | 0.06% | +460.0% |
Q1 2018 | $1,260,000 | -74.7% | 34,016 | -83.0% | 0.01% | -54.5% |
Q3 2017 | $4,978,000 | +42.7% | 200,000 | 0.0% | 0.02% | +15.8% |
Q2 2017 | $3,488,000 | – | 200,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |